Literature DB >> 324668

Immune complex detection by immunofluorescence on polymorphonuclear leucocytes.

J W Steffelaar, F J Ten Kate, M Nap, A J Swaak, C B De Graaffreitsma, E H Van Elven, T M Feltkamp-Vroom.   

Abstract

Polymorphonuclear leucocytes (PMN) from patients with systemic lupus erythematosus (SLE) were isolated from defibrinated and heparinized blood. In addition, PMN from a healthy donor were incubated with sera from SLE patients and with sera containing artificially prepared immune complexes of hepatitis B surface antigen (HBsAg) and human anti-HBsAg immunoglobulin (anti-HBs) with well defined variations of the antigen/antibody ratio. To one group of blood samples, 5 mM monoiodine acetic acid (MIAA) was added to block in vitro phagocytosis. The Pmn were examined for the presence of IgG, IgM, and HBsAg by the immunofluorescence technique. PMN from defibrinated blood of SLE patients showed in up to 80% immunoglobulin (Ig)-inclusions. However, addition of 5 mM MIAA reduced the number of Ig-containing PMN to at most 40%, which levels were equal to numbers found in specimens from heparinized blood. Addition of 5 mM MIAA to heparinized blood did not reduce the number of PMN with Ig inclusions. Normal donor PMN isolated from defibrinated, heparinized, and EDT blood showed equal amounts of Ig inclusions after incubation with SLE sera, but none when MIAA had been added. In PMN incubated with HBsAg-anti HBs immune complexes with an antigen antibody ratio between 5 and 0-2, both HBsAg and IgG could be detected. It is concluded that Ig inclusions in PMN from heparinized blood from SLE patients are due to in vivo phagocytosis, presumably of circulating immune complexes. In vitro phagocytosis of Ig from SLE sera by normal donor PMN also suggests the presence of immune complexes. Dependent on the antigen-antibody ratio, artificial HBsAg/anti-HBs immune complexes can be detected by in vitro phagocytosis by PM.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324668      PMCID: PMC1540934     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

2.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane.

Authors:  B Combes; J Shorey; A Barrera; P Stastny; E H Eigenbrodt; A R Hull; N W Carter
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

3.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

4.  Pathogenesis of renal disease associated with viral hepatitis.

Authors:  M R Knieser; E H Jenis; D T Lowenthal; W H Bancroft; W Burns; R Shalhoub
Journal:  Arch Pathol       Date:  1974-04

5.  Membrano-proliferative glomerulonephritis associated with persistent viral hepatitis.

Authors:  B D Myers; B Griffel; D Naveh; T Jankielowiiz; A Klajman
Journal:  Am J Clin Pathol       Date:  1973-08       Impact factor: 2.493

6.  Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases.

Authors:  J H Vaughan; E V Barrnett; M V Sobel; R F Jacox
Journal:  Arthritis Rheum       Date:  1968-04

7.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

8.  Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes.

Authors:  P F Kohler; R E Cronin; W S Hammond; D Olin; R I Carr
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

9.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

10.  Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.

Authors:  A Cats; G J Lafeber; F Klein
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

View more
  12 in total

1.  Circulating immune complexes in untreated psoriasis. A comparison of Raji-cell radioimmunoassay and polymorphonuclear leukocyte phagocytosis.

Authors:  L Lindholm; H Mobacken; B L Magnusson
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Correlation of disease activity and Clq-binding immune complexes with the neutrophil inclusions which form in the presence of SLE sera.

Authors:  E R Hurd; H E Jasin; J N Gilliam
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

4.  Gold binding to blood cells and serum proteins during chrysotherapy.

Authors:  R J van de Stadt; B Abbo-Tilstra
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

5.  The kinetics of leucocyte migration into rabbit knee joints elicited by preformed immune complexes with different in vitro characteristics.

Authors:  L M Bjursten; P Thomsen; S Ahlstedt; U Bagge
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

6.  Strain differences in mice in carbon tetrachloride-induced liver injury.

Authors:  P S Bhathal; N R Rose; I R Mackay; S Whittingham
Journal:  Br J Exp Pathol       Date:  1983-10

7.  Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

Authors:  J van der Maulen; A A Wouda; E Mandema; T H The
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

8.  Inhibition of polymorphonuclear leukocyte chemiluminescence for detection of immune complexes in human sera.

Authors:  N J Doll; M R Wilson; J E Salvaggio
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients.

Authors:  T H The; M van der Giessen; H A Huiges; H Schraffordt Koops; I van Wingerden
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

10.  Some characteristics of neutrophils from diabetic patients and their relation to the levels of circulating immune complexes.

Authors:  R I Barañao; L S Rumi; P A Tesone; V G Foglia
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.